Atom | Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Funder: National Institutes of Health

Funding Amounts: Up to $475,000 direct costs over 4 years; no more than $250,000 in any single year; maximum project period is 4 years.

Summary: Supports observational studies to inform the design of future clinical research in musculoskeletal, rheumatic, or skin diseases; clinical trials are not allowed.

Key Information: Only observational (non-interventional) studies are eligible; applications proposing clinical trials or basic/lab research will not be reviewed.

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing